CIK 0001607678 · Large accelerated filer
Viking Therapeutics, Inc.
Sign in to watch- Ticker
- VKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461073877
- Phone
- 858-704-4660
- Business address
- 9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-17 | Mancini Marianna Chief Operating Officer | Option exercise · Stock Option (Right to Buy) | −12,500 | 0 | ||
| 2023-04-17 | ZANTE GREG Chief Financial Officer | Option exercise | +7,500 | $13.07 | $98K | 156,779 |
| 2023-04-17 | ZANTE GREG Chief Financial Officer | Sale | −7,500 | $20.00 | $150K | 149,279 |
| 2023-04-17 | ZANTE GREG Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −7,500 | 0 | ||
| 2023-04-13 | Lian Brian President & CEO | Option exercise | +54,336 | $1.88 | $102K | 2,387,299 |
| 2023-04-13 | Lian Brian President & CEO | Sale | −79,336 | $18.45 | $1.5M | 2,307,963 |
| 2023-04-13 | Lian Brian President & CEO | Option exercise · Stock Option (right to buy) | −54,336 | 0 | ||
| 2023-04-12 | ZANTE GREG Chief Financial Officer | Option exercise | +37,447 | $5.80 | $217K | 186,726 |
| 2023-04-12 | ZANTE GREG Chief Financial Officer | Option exercise | +4,097 | $7.77 | $32K | 190,823 |
| 2023-04-12 | ZANTE GREG Chief Financial Officer | Sale | −41,544 | $18.00 | $748K | 149,279 |
| 2023-04-12 | ZANTE GREG Chief Financial Officer | Option exercise · Stock Option (right to buy | −37,447 | 26,000 | ||
| 2023-04-12 | ZANTE GREG Chief Financial Officer | Option exercise · Stock Option (right to buy) | −4,097 | 12,750 | ||
| 2023-04-11 | ZANTE GREG Chief Financial Officer | Option exercise | +3,242 | $7.77 | $25K | 152,521 |
| 2023-04-11 | ZANTE GREG Chief Financial Officer | Option exercise | +8,500 | $4.68 | $40K | 161,021 |
| 2023-04-11 | ZANTE GREG Chief Financial Officer | Option exercise | +30,000 | $4.88 | $146K | 191,021 |
| 2023-04-11 | ZANTE GREG Chief Financial Officer | Option exercise | +14,553 | $5.80 | $84K | 205,574 |
| 2023-04-11 | ZANTE GREG Chief Financial Officer | Sale | −56,295 | $18.00 | $1.0M | 149,279 |
| 2023-04-11 | ZANTE GREG Chief Financial Officer | Option exercise · Stock Option (right to buy) | −3,242 | 16,847 | ||
| 2023-04-11 | ZANTE GREG Chief Financial Officer | Option exercise · Stock Option (right to buy | −8,500 | 8,500 | ||
| 2023-04-11 | ZANTE GREG Chief Financial Officer | Option exercise · Stock Option (right to buy | −30,000 | 90,000 |
Page 14 of 27 · 528 trades